| Clinical analysis of anti-Ma2-associated encephalitis J Dalmau, F Graus, A Villarejo, JB Posner, D Blumenthal, B Thiessen, ... Brain 127 (8), 1831-1844, 2004 | 847 | 2004 |
| Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease T Moreno-Ramos, J Benito-León, A Villarejo, F Bermejo-Pareja Journal of Alzheimer's Disease 34 (3), 659-664, 2013 | 211 | 2013 |
| Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin E Carro, F Bartolomé, F Bermejo-Pareja, A Villarejo-Galende, JA Molina, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 8, 131-138, 2017 | 174 | 2017 |
| Syndrome and outcome of antibody‐negative limbic encephalitis F Graus, D Escudero, L Oleaga, J Bruna, A Villarejo‐Galende, ... European Journal of Neurology 25 (8), 1011-1016, 2018 | 145 | 2018 |
| Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease GSGVA Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S New England Journal of Medicine 389 (20), 1862-1876, 2023 | 144 | 2023 |
| Cholinergic–dopaminergic imbalance in Pisa syndrome A Villarejo, A Camacho, R García–Ramos, T Moreno, M Penas, R Juntas, ... Clinical neuropharmacology 26 (3), 119-121, 2003 | 139 | 2003 |
| Utilidad de los test breves en el cribado de demencia A Villarejo, V Puertas-Martín Neurología 26 (7), 425-433, 2011 | 117 | 2011 |
| Mortality from Parkinson's disease: a population‐based prospective study (NEDICES) IJ Posada, J Benito‐León, ED Louis, R Trincado, A Villarejo, MJ Medrano, ... Movement Disorders 26 (14), 2522-2529, 2011 | 113 | 2011 |
| Dementia-associated mortality at thirteen years in the NEDICES Cohort Study A Villarejo, J Benito-León, R Trincado, IJ Posada, V Puertas-Martín, ... Journal of Alzheimer's Disease 26 (3), 543-551, 2011 | 112 | 2011 |
| Spontaneous ARIA-like events in cerebral amyloid angiopathy–related inflammation: a multicenter prospective longitudinal cohort study L Antolini, JC DiFrancesco, M Zedde, G Basso, A Arighi, A Shima, ... Neurology 97 (18), e1809-e1822, 2021 | 109 | 2021 |
| Plasma Aβ42/40 ratio detects early stages of Alzheimer’s disease and correlates with CSF and neuroimaging biomarkers in the AB255 study V Pérez-Grijalba, J Romero, P Pesini, L Sarasa, I Monleón, I San-José, ... The journal of prevention of Alzheimer's disease 6, 34-41, 2019 | 108 | 2019 |
| Decreased salivary lactoferrin levels are specific to Alzheimer's disease M González-Sánchez, F Bartolome, D Antequera, V Puertas-Martín, ... EBioMedicine 57, 2020 | 93 | 2020 |
| Physical activity as protective factor against dementia: a prospective population-based study (NEDICES) S Llamas-Velasco, I Contador, A Villarejo-Galende, D Lora-Pablos, ... Journal of the International Neuropsychological Society 21 (10), 861-867, 2015 | 78 | 2015 |
| Informe de la Fundación del Cerebro. Impacto social de la enfermedad de Alzheimer y otras demencias A Villarejo Galende, M Eimil Ortiz, S Llamas Velasco, M Llanero Luque, ... Neurología (Barc., Ed. impr.), 39-49, 2021 | 75 | 2021 |
| Aplicación práctica de los test cognitivos breves J Olazarán, MC Hoyos-Alonso, T Del Ser, AG Barral, JL Conde-Sala, ... Neurología 31 (3), 183-194, 2016 | 74 | 2016 |
| Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study AIAV Hana Florian, Deli Wang, Steven E Arnold, Mercè Boada, Qi Guo, Ziyi Jin ... Brain 146 (6), 2275–2284., 2023 | 69 | 2023 |
| Report by the Spanish Foundation of the Brain on the social impact of Alzheimer disease and other types of dementia A Villarejo Galende, M Eimil Ortiz, S Llamas Velasco, M Llanero Luque, ... Report by the Spanish Foundation of the Brain on the social impact of …, 2021 | 69* | 2021 |
| Population-based case–control study of cognitive function in early Parkinson's disease (NEDICES) J Benito-León, ED Louis, IJ Posada, Á Sánchez-Ferro, R Trincado, ... Journal of the neurological sciences 310 (1-2), 176-182, 2011 | 67 | 2011 |
| Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial ABSGI B Dubois, JL López-Arrieta, S Lipschitz Alzheimer's Research & Therapy 15 (39), 2023 | 62 | 2023 |
| Kynurenic acid levels are increased in the CSF of Alzheimer’s disease patients M González-Sánchez, J Jiménez, A Narváez, D Antequera, ... Biomolecules 10 (4), 571, 2020 | 62 | 2020 |
